UCL Division of Psychiatry and Camden Learning Disability Service, London, UK.
Psychological Medicine, University of Glasgow, UK.
Res Dev Disabil. 2022 May;124:104202. doi: 10.1016/j.ridd.2022.104202. Epub 2022 Mar 3.
The minimal clinically important difference (MCID) is relevant in the estimation of improvement in a patient outcome.
To determine the MCID on the Aberrant Behaviour Checklist-Irritability (ABC-I), widely used to measure the effects of intervention for aggressive challenging behaviour in people with intellectual disabilities.
We utilised distribution and anchor based methods to estimate the ABC-I MCID. We extracted data from 15 randomised controlled trials (RCTs) for meta-analysis. We conducted three online workshops with family carers and professionals to consider meaningful change in case vignettes of increasing severity of aggressive challenging behaviour.
We did not find overlap in the range of values between the two approaches. The meta-analysis indicated a range of MCID on the ABC-I (0.05, 4.94) whilst the anchor-based estimation indicated a larger change (6.6, 16.6).
The MCID is essential in interpreting the results from intervention studies. The present work was undertaken as part of a wider programme on the development and testing of a psychosocial intervention for aggressive challenging behaviour, and it is of interest to researchers in justifying how they choose and determine the MCID on the outcome of interest.
最小临床重要差异(MCID)在评估患者结局的改善方面具有重要意义。
确定广泛用于衡量智力残疾者攻击性行为干预效果的异常行为检查表-易怒性(ABC-I)的 MCID。
我们利用分布和锚定方法来估计 ABC-I 的 MCID。我们从 15 项随机对照试验(RCT)中提取数据进行荟萃分析。我们与家庭照顾者和专业人员进行了三次在线研讨会,以考虑案例中攻击性挑战行为严重程度不断增加的情况下的有意义变化。
我们没有发现两种方法的数值范围有重叠。荟萃分析表明 ABC-I 的 MCID 范围为(0.05,4.94),而基于锚定的估计则表明更大的变化(6.6,16.6)。
MCID 对于解释干预研究的结果至关重要。本工作是一项更广泛的心理社会干预攻击性行为研究计划的一部分,对于研究人员来说,如何选择和确定他们感兴趣的结果的 MCID 具有重要意义。